NeoCare Inc. develops non-invasive, affordable diagnostic tools for newborns, targeting anemia, jaundice, and hypoxia. Its flagship device, Samira, delivers painless, real-time results with IoT integration for EHR access. Backed by peer-reviewed research and a US provisional patent, NeoCare also advances point-of-care testing for bladder cancer, streamlining diagnostics across age groups and care settings.